Danaher Corp.
http://www.danaher.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Danaher Corp.
Medtechs Drive To Keep The Status Quo In A Year Like No Other
The performances of the leading medtechs in the first year of the COVID-19 pandemic were impossible to compare and certainly unrepresentative of normal business cycles and competitive activity. Elective care was largely put on hold and emergency needs boosted exceptional demand for certain product types. More than anything else, 2020 tested management skills and planning.
MTI 100 Review: Medtechs Drive To Keep The Status Quo In A Year Like No Other
The performances of the leading medtechs in the first year of the COVID pandemic were impossible to compare and certainly unrepresentative of normal business cycles and competitive activity. Elective care was largely put on hold and emergency needs boosted exceptional demand for certain product types. More than anything else, 2020 tested management's planning skills.
Point Of Care Diagnostics Market Projected To Continue Rapid Growth
A new report from Informa's Meddevicetracker highlights strong projected growth in the market, explaining the underlying reasons why.
Tech Transfer Roundup: Mydecine, Johns Hopkins Pair Up To Study Psychedelics
BioMed X teams with J&J on inflammation, drug delivery research. Stem cell firm Calidi inks licensing deals with U. of Chicago, City of Hope and Northwestern. MD Anderson teams with Blueprint and Hummingbird.
Company Information
- Industry
- In Vitro Diagnostics
- Medical Devices
- Research, Analytical Equipment & Supplies
- Other Names / Subsidiaries
-
- Beckman Coulter
- Cepheid
- Cytiva
- GE Life Sciences
- Hybritech
- Pall Corporation
- Radiometer Medical ApS
- HemoCue AB
- Integrated DNA Technologies, Inc.
- Leica Microsystems Inc.
- Leica Biosystems Inc.
- Vision Systems Ltd.
- Coretech Holdings, LLC
- Q3DM Inc.
- Aldevron LLC